Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Goodfellow Gems #156
Wednesday 15 September 2021, 12:10 AM

“Time to switch from ACE inhibitors to ARBs – same efficacy but safer”
A head-to-head comparison trial of angiotensin II receptor blockers versus ACE inhibitors exhibited no difference in outcomes except for fewer drug wi
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. mayocl.in/2WniHF5 (Mayo Clin Proc 2016;91[1]:51– 60).
2. bit.ly/3yeMVa8 (Hypertension 2021;78[3]:591–603).